(Q38559308)

4 September 2017

1 reference

title

Evolving targeted therapies for right ventricular failure (English)

1 reference

4 September 2017

Thomas G Di Salvo

1

1 reference

4 September 2017

language of work or name

English

0 references

publication date

3 August 2015

1 reference

Expert Opinion on Biological Therapy

4 September 2017

published in

1 reference

4 September 2017

volume

15

1 reference

4 September 2017

issue

9

1 reference

4 September 2017

page(s)

1263-1283

1 reference

New mechanistic and therapeutic targets for pediatric heart failure: report from a National Heart, Lung, and Blood Institute working group.

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Assessment and treatment of right ventricular failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Right-ventricular failure following left ventricle assist device implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Anatomy and physiology of the right ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Right versus left ventricular failure: differences, similarities, and interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Myocardial recovery and the failing heart: myth, magic, or molecular target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Contemporary management of tricuspid regurgitation: an updated clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Management of the failing Fontan circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Implantable continuous-flow right ventricular assist device: lessons learned in the development of a cleveland clinic device

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Epigenetic mechanisms in heart failure pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Heart structure-specific transcriptomic atlas reveals conserved microRNA-mRNA interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

MicroRNAs add a new dimension to cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

MicroRNAs in right ventricular (dys)function (2013 Grover Conference series).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Noncoding RNAs and myocardial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Noncoding RNA expression in myocardium from infants with tetralogy of Fallot.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

MicroRNAs in heart failure: is the picture becoming less miRky?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

MicroRNA-133 controls cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

MicroRNA-34a regulates cardiac ageing and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Inhibition of miR-25 improves cardiac contractility in the failing heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

MicroRNA regulation and cardiac calcium signaling: role in cardiac disease and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Developing microRNA therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Transcriptional regulation and its misregulation in disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Emerging roles for chromatin as a signal integration and storage platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

BET-ting on chromatin-based therapeutics for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Histone recognition and large-scale structural analysis of the human bromodomain family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

RNA polymerase II elongation control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

BET bromodomains mediate transcriptional pause release in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

BET acetyl-lysine binding proteins control pathological cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Epigenetic protein families: a new frontier for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

The noncoding RNA revolution-trashing old rules to forge new ones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Dogma derailed: the many influences of RNA on the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Structure and function of long noncoding RNAs in epigenetic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

lincRNAs: genomics, evolution, and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Long noncoding RNAs: cellular address codes in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Long noncoding RNAs: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Genome regulation by long noncoding RNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Targeting long non-coding RNA to therapeutically upregulate gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Missing links in cardiology: long non-coding RNAs enter the arena

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Epigenetic coordination of embryonic heart transcription by dynamically regulated long noncoding RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heart-specific long non-coding RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Getting to the heart of the matter: long non-coding RNAs in cardiac development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

A long noncoding RNA protects the heart from pathological hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

A guide to genome engineering with programmable nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Next-generation models of human cardiogenesis via genome editing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

RNA-guided human genome engineering via Cas9

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Potential of gene therapy as a treatment for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Gene therapy to treat cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Cardiovascular gene therapy for myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Controlled expression of cardiac-directed adenylylcyclase type VI provides increased contractile function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Long-term effects of AAV1/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Design of a phase 2b trial of intracoronary administration of AAV1/SERCA2a in patients with advanced heart failure: the CUPID 2 trial (calcium up-regulation by percutaneous administration of gene therapy in cardiac disease phase 2b).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Modeling CVD in human pluripotent cells by genome editing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Adeno-associated virus vectors as therapeutic and investigational tools in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Pre-existing anti-adeno-associated virus antibodies as a challenge in AAV gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Heart regeneration in zebrafish

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Transient regenerative potential of the neonatal mouse heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Existing cardiomyocytes generate cardiomyocytes at a low rate after birth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Evidence for cardiomyocyte renewal in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Adult cardiac stem cells are multipotent and support myocardial regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Cardiac regenerative capacity and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Cellular reprogramming: a new avenue to cardiac regeneration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Breakthroughs in cell therapy for heart disease: focus on cardiosphere-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Exosomes and cardiac repair after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Preparing the ground for tissue regeneration: from mechanism to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Cell therapy for cardiac repair--lessons from clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Right ventricular failure secondary to chronic overload in congenital heart diseases: benefits of cell therapy using human embryonic stem cell-derived cardiac progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

At a crossroad: cell therapy for cardiac repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Implementation of cardovascular cell therapy network trials: challenges, innovation and lessons learned from experience in the CCTRN

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Translating stem cell research to cardiac disease therapies: pitfalls and prospects for improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Stem cells in the management of advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

CD34+ stem cell therapy in nonischemic dilated cardiomyopathy patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Intramyocardial, autologous CD34+ cell therapy for refractory angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Mesenchymal stem cell insights: prospects in cardiovascular therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Regenerating new heart with stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Making it stick: chasing the optimal stem cells for cardiac regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

c-kit+ cells minimally contribute cardiomyocytes to the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Cardiac stem cell therapy for cardiac repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Recent developments in cardiovascular stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Induced pluripotent stem cells: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Induced pluripotent stem cells in cardiovascular drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Modeling inherited cardiac disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Reprogramming the cardiac field

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Induction of human cardiomyocyte-like cells from fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Heart repair by reprogramming non-myocytes with cardiac transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Functional screening identifies miRNAs inducing cardiac regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Reprogramming of human fibroblasts toward a cardiac fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Epigenetics of reprogramming to induced pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Chromatin-modifying enzymes as modulators of reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Reprogramming in vivo produces teratomas and iPS cells with totipotency features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Induced regeneration--the progress and promise of direct reprogramming for heart repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Heart repair by cardiac reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Direct cardiac reprogramming: from developmental biology to cardiac regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Fibroblast-mediated pathways in cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Conversion of human fibroblasts to angioblast-like progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Myocardial Notch signaling reprograms cardiomyocytes to a conduction-like phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Direct conversion of quiescent cardiomyocytes to pacemaker cells by expression of Tbx18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Cardiac tissue engineering: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Protein engineering for cardiovascular therapeutics: untapped potential for cardiac repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Biomaterials to enhance stem cell function in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Bioengineering heart muscle: a paradigm for regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Patching the heart: cardiac repair from within and outside

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Growth of engineered human myocardium with mechanical loading and vascular coculture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Pathobiology of pulmonary arterial hypertension and right ventricular failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Heart failure gene therapy: the path to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Cardiopoietic Stem Cell Therapy in Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

Myoblast transplantation for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1054277

10.1517/14712598.2015.1054277

21 January 2018

Identifiers

DOI

1 reference

release_vsxkhgwrbvfppcat2qiwlujbgm

4 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vsxkhgwrbvfppcat2qiwlujbgm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference